Tuesday 30th August 2022 |
Text too small? |
In accordance with Listing Rule 4.14.2, Comvita Limited (CVT) announces its intention to acquire up to 96,000 of its ordinary shares in relation to proposed share scheme arrangements for employees. Under the share buy-back programme announced 27 May 2022 to purchase 300,000 shares, 204,000 shares were purchased. This current programme is completing the acquisition of the 300,000 shares.
Offer date: The maximum period which offers will be made is from and including 5 September 2022 (being three clear business days after the date of this Notice) to 31 October 2022.
Equity securities to be acquired: The equity securities to be acquired are up to a total of 96,000 ordinary shares, being approximately 0.14% of CVT’s total ordinary shares.
Brett Hewlett
Chair
David Banfield
CEO
Ends.
This announcement was authorised for release by the Board of directors of Comvita Limited.
For further information contact:
Kelly Bennett, One Plus One Communications
Mobile: +64 21 380 035
Email: kelly.bennett@oneplusonegroup.co.nz
Background information
Comvita (NZX: CVT ) was founded in 1974, with a purpose to heal and protect the world through the natural power of the hive. With a team of 500+ people globally, united with more than 1.6 billion bees, we are the global market leader in Mānuka honey and bee consumer goods. Seeking to understand, but never to alter, we test and verify all our bee-product ingredients are of the highest quality in our own government-recognised and accredited laboratory. We are growing industry scientific knowledge on bee welfare, Mānuka trees and the many benefits of Mānuka honey and propolis. We have pledged to be carbon neutral by 2025 and carbon positive by 2030, and we are planting more than two million native trees every year. Comvita has operations in Australia, China, North America, South East Asia, and Europe – and of course, Aotearoa New Zealand, where our bees are thriving.
Comvita share buy-back programme
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b